CervoMed Inc. Net Income (Loss) Available to Common Stockholders, Basic
CervoMed Inc. (CRVO) reported Net Income (Loss) Available to Common Stockholders, Basic of -$24.10 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-18.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2022-03-18
- CervoMed Inc. net income (loss) available to common stockholders, basic for the quarter ending 2021-12-31 was -$3.47M.
- CervoMed Inc. net income (loss) available to common stockholders, basic for the quarter ending 2021-09-30 was -$12.20M.
- CervoMed Inc. net income (loss) available to common stockholders, basic for the quarter ending 2021-06-30 was -$3.78M.
- CervoMed Inc. net income (loss) available to common stockholders, basic for the quarter ending 2021-03-31 was -$4.64M.
- CervoMed Inc. net income (loss) available to common stockholders, basic for fiscal 2021 was -$24.10M.
- CervoMed Inc. net income (loss) available to common stockholders, basic for fiscal 2020 was -$16.14M.
- CervoMed Inc. net income (loss) available to common stockholders, basic for fiscal 2019 was -$11.80M.
- CervoMed Inc. net income (loss) available to common stockholders, basic for fiscal 2018 was -$26.62M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | -$15.67M derived: sum of 2 quarters · filed 2022-03-18 | -$19.45M derived: sum of 3 quarters · filed 2022-03-18 | -$24.10M 10-K · filed 2022-03-18 | ||||
| 2021-09-30 | -$12.20M 10-Q · filed 2021-11-10 | -$15.98M derived: sum of 2 quarters · filed 2021-11-10 | -$20.62M 10-Q · filed 2021-11-10 | -$24.68M derived: sum of 4 quarters · filed 2022-03-18 | ||||
| 2021-06-30 | -$3.78M 10-Q · filed 2021-08-11 | -$8.42M 10-Q · filed 2021-08-11 | -$12.48M derived: sum of 3 quarters · filed 2022-03-18 | -$16.92M derived: sum of 4 quarters · filed 2022-03-18 | ||||
| 2021-03-31 | -$4.64M derived: 10-K 12 month − 3 quarters · filed 2022-03-18 | -$8.71M derived: sum of 2 quarters · filed 2022-03-18 | -$13.15M derived: sum of 3 quarters · filed 2022-03-18 | -$18.22M derived: sum of 4 quarters · filed 2022-03-18 | ||||
| 2020-12-31 | -$4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | -$8.50M derived: sum of 2 quarters · filed 2022-03-18 | -$13.58M derived: sum of 3 quarters · filed 2022-03-18 | -$16.14M 10-K · filed 2022-03-18 | ||||
| 2020-09-30 | -$4.44M 10-Q · filed 2021-11-10 | -$9.51M derived: sum of 2 quarters · filed 2021-11-10 | -$12.07M 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | -$5.08M 10-Q · filed 2021-08-11 | -$7.63M 10-Q · filed 2021-08-11 | ||||||
| 2019-12-31 | -$3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | -$6.56M derived: sum of 2 quarters · filed 2021-03-17 | -$9.05M derived: sum of 3 quarters · filed 2021-03-17 | -$11.80M 10-K · filed 2021-03-17 | ||||
| 2019-09-30 | -$2.80M 10-Q · filed 2020-11-12 | -$5.30M derived: sum of 2 quarters · filed 2020-11-12 | -$8.05M 10-Q · filed 2020-11-12 | -$13.62M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | -$2.50M 10-Q · filed 2020-08-07 | -$5.24M 10-Q · filed 2020-08-07 | -$10.81M derived: sum of 3 quarters · filed 2020-08-07 | -$17.53M derived: sum of 4 quarters · filed 2020-08-07 | ||||
| 2019-03-31 | -$2.75M 10-Q · filed 2019-05-09 | -$8.32M derived: sum of 2 quarters · filed 2020-03-17 | -$15.04M derived: sum of 3 quarters · filed 2020-03-17 | -$17.80M derived: sum of 4 quarters · filed 2020-03-17 | ||||
| 2018-12-31 | -$5.57M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | -$12.29M derived: sum of 2 quarters · filed 2020-03-17 | -$15.06M derived: sum of 3 quarters · filed 2020-03-17 | -$26.62M 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | -$6.72M 10-Q · filed 2019-11-08 | -$9.48M derived: sum of 2 quarters · filed 2019-11-08 | -$21.05M 10-Q · filed 2019-11-08 | -$19.60M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | -$2.77M 10-Q · filed 2019-08-08 | -$14.33M 10-Q · filed 2019-08-08 | -$12.88M derived: sum of 3 quarters · filed 2019-08-08 | -$9.99M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$11.57M 10-Q · filed 2019-05-09 | -$10.12M derived: sum of 2 quarters · filed 2019-05-09 | -$7.23M derived: sum of 3 quarters · filed 2019-05-09 | $12.67M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | $4.34M derived: sum of 2 quarters · filed 2019-03-19 | $24.24M derived: sum of 3 quarters · filed 2019-03-19 | -$2.62M 10-K · filed 2019-03-19 | ||||
| 2017-09-30 | $2.89M 10-Q · filed 2018-11-13 | $22.79M derived: sum of 2 quarters · filed 2018-11-13 | -$4.07M 10-Q · filed 2018-11-13 | -$8.48M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $19.90M 10-Q · filed 2018-08-10 | $9.48M 10-Q · filed 2017-08-14 | -$8.80M 10-Q · filed 2018-08-10 | -$11.37M derived: sum of 3 quarters · filed 2018-08-10 | -$16.80M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2017-03-31 | -$28.70M 10-Q · filed 2018-05-10 | -$31.27M derived: sum of 2 quarters · filed 2018-05-10 | -$36.70M derived: sum of 3 quarters · filed 2018-05-10 | -$40.51M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | -$2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$8.01M derived: sum of 2 quarters · filed 2018-04-02 | -$11.81M derived: sum of 3 quarters · filed 2018-04-02 | -$18.04M 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | -$5.44M 10-Q · filed 2017-11-13 | -$9.24M derived: sum of 2 quarters · filed 2017-11-13 | -$15.47M 10-Q · filed 2017-11-13 | -$35.29M derived: sum of 4 quarters · filed 2017-11-13 | ||||
| 2016-06-30 | -$3.81M 10-Q · filed 2017-08-14 | -$10.03M 10-Q · filed 2017-08-14 | -$29.85M derived: sum of 3 quarters · filed 2017-08-14 | -$43.08M derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | -$6.22M 10-Q · filed 2017-05-15 | -$26.05M derived: sum of 2 quarters · filed 2017-05-15 | -$39.27M derived: sum of 3 quarters · filed 2017-05-15 | -$43.24M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | -$19.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | -$33.05M derived: sum of 2 quarters · filed 2016-03-25 | -$37.02M derived: sum of 3 quarters · filed 2016-03-25 | -$23.82M 10-K · filed 2016-03-25 | ||||
| 2015-09-30 | -$13.22M 10-Q · filed 2015-11-12 | -$17.19M derived: sum of 2 quarters · filed 2015-11-12 | -$4.00M 10-Q · filed 2016-11-14 | -$20.71M 10-Q · filed 2015-11-12 | -$23.51M derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2015-06-30 | -$3.97M 10-Q · filed 2015-08-12 | -$2.57M 10-Q · filed 2016-08-15 | -$7.49M 10-Q · filed 2015-08-12 | -$10.28M derived: sum of 3 quarters · filed 2016-05-16 | -$13.73M derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2015-03-31 | -$1.24M 10-Q · filed 2016-05-16 | -$3.52M 10-Q · filed 2015-05-11 | -$6.31M derived: sum of 2 quarters · filed 2016-05-16 | -$9.76M derived: sum of 3 quarters · filed 2016-05-16 | -$14.22M derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2014-12-31 | -$5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | -$8.52M derived: sum of 2 quarters · filed 2016-03-25 | -$12.97M derived: sum of 3 quarters · filed 2016-03-25 | -$14.35M 10-K · filed 2016-03-25 | ||||
| 2014-09-30 | -$3.45M 10-Q · filed 2015-11-12 | -$7.90M derived: sum of 2 quarters · filed 2015-11-12 | -$9.28M 10-Q · filed 2015-11-12 | -$10.09M derived: sum of 4 quarters · filed 2015-11-12 | ||||
| 2014-06-30 | -$4.46M 10-Q · filed 2015-08-12 | -$5.84M 10-Q · filed 2015-08-12 | -$6.65M derived: sum of 3 quarters · filed 2015-08-12 | -$8.17M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2014-03-31 | -$1.38M 10-Q · filed 2015-05-11 | -$2.19M derived: sum of 2 quarters · filed 2015-05-11 | -$3.72M derived: sum of 3 quarters · filed 2015-05-11 | -$1.41M derived: sum of 4 quarters · filed 2015-05-11 | ||||
| 2013-12-31 | -$809.78K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-03 | -$2.34M derived: sum of 2 quarters · filed 2015-04-03 | -$34.82K derived: sum of 3 quarters · filed 2015-04-03 | -$2.64M 10-K · filed 2015-04-03 | ||||
| 2013-09-30 | -$1.53M 10-Q · filed 2014-11-12 | $774.96K derived: sum of 2 quarters · filed 2014-11-12 | -$1.83M 10-Q · filed 2014-11-12 | $13.96M derived: sum of 4 quarters · filed 2014-11-12 | ||||
| 2013-06-30 | $2.30M 10-Q · filed 2014-08-14 | -$300.92K 10-Q · filed 2014-08-14 | $15.49M derived: sum of 3 quarters · filed 2014-08-14 | $14.03M derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | -$2.60M 10-Q · filed 2014-05-20 | $13.19M derived: sum of 2 quarters · filed 2014-05-20 | $11.73M derived: sum of 3 quarters · filed 2014-05-20 | $10.29M derived: sum of 4 quarters · filed 2014-05-20 | ||||
| 2012-12-31 | $15.79M derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-20 | $14.33M derived: sum of 2 quarters · filed 2014-05-20 | $12.89M derived: sum of 3 quarters · filed 2014-05-20 | -$7.37M 10-Q · filed 2014-05-20 | -$7.35M 10-K/A · filed 2013-04-24 | |||
| 2012-09-30 | -$1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | -$2.90M derived: sum of 2 quarters · filed 2013-11-19 | -$23.16M 10-Q · filed 2013-11-19 | |||||
| 2012-06-30 | -$1.44M 10-Q · filed 2013-11-19 | -$21.27M 10-Q · filed 2013-08-14 | -$21.70M 10-Q · filed 2013-08-14 | |||||
| 2012-03-31 | -$415.14K 10-Q/A · filed 2013-05-20 | |||||||
| 2011-12-31 | -$23.03M 10-K/A · filed 2013-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |